

Health Library
October 10, 2025
Question on this topic? Get an instant answer from August.
ʻO Lisocabtagene maraleucel kahi lapaʻau maʻi maʻi e hoʻohana ana i kāu mau pūnaewele pale ponoʻī e hakakā i kekahi mau maʻi koko. ʻO kēia lapaʻau pilikino, i ʻike ʻia hoʻi ʻo CAR-T cell therapy, e lawe i kāu mau T cells (he ʻano keʻokeʻo koko), hoʻololi iā lākou i loko o kahi hale hana e ʻike maikaʻi a hoʻouka i nā pūnaewele maʻi maʻi, a laila hoʻokomo iā lākou i loko o kou kino.
Inā ua ʻōlelo ʻia ʻoe a i ʻole kekahi mea aloha i kēia lapaʻau, nui paha kāu mau nīnau e pili ana i ke ʻano o ka hana a me ka mea e manaʻo ai. Hōʻike kēia ala hana hou i ka manaʻolana no ka poʻe me kekahi mau lymphomas i pane ʻole i nā lapaʻau ʻē aʻe, e hāʻawi ana i kahi ala hou e hoʻohana ai i kāu ʻōnaehana pale kūlohelohe o ke kino e kūʻē i ka maʻi maʻi.
ʻO Lisocabtagene maraleucel he ʻano immunotherapy i kapa ʻia ʻo CAR-T cell therapy i hoʻolālā ʻia e mālama i kekahi mau maʻi koko. Hana ʻia ka lāʻau lapaʻau no kēlā me kēia maʻi ma ka hoʻohana ʻana i kā lākou mau pūnaewele pale ponoʻī, i hōʻiliʻili ʻia, hoʻololi ʻia i ka genetic i loko o kahi hale hana kūikawā, a laila hāʻawi ʻia ma o ka IV infusion.
No kēia lapaʻau i kahi papa o nā lāʻau lapaʻau i kapa ʻia ʻo
Ua ʻae ʻia ʻo Lisocabtagene maraleucel e mālama i nā pākeke me kekahi mau ʻano o ka lymphoma nui B-cell i hoʻi mai ma hope o nā lāʻau lapaʻau mua a i ʻole ʻaʻole i pane i ka liʻiliʻi o ʻelua mau ʻano lapaʻau like ʻole. Aia kēia mau mea i ka diffuse large B-cell lymphoma, high-grade B-cell lymphoma, a me ka primary mediastinal large B-cell lymphoma.
E ʻōlelo maʻamau kāu kauka i kēia lapaʻau ke hana ʻole nā lāʻau lapaʻau maʻamau ʻē aʻe a i ʻole i ka wā i hoʻi mai ai ka maʻi maʻi ma hope o ka pane mua ʻana i ka lapaʻau. Ua manaʻo ʻia he mea a nā kauka e kapa ai he
Ma hope o ka hoʻololi ʻia ʻana o nā keena a hoʻonui ʻia i loko o ka hale hana, ua paʻa lākou a hoʻouna ʻia i kāu kikowaena lapaʻau. Ke loaʻa iā ʻoe ka infusion, e hele ana kēia mau T-cells i hoʻomaikaʻi ʻia i loko o kou kino, e ʻimi ana a luku i nā keena lymphoma ma nā wahi a lākou e loaʻa ai. Hiki i nā keena i hoʻololi ʻia ke hoʻomau i ka hana no nā mahina a i ʻole nā makahiki ma hope o ka lapaʻau mua.
Ua manaʻo ʻia kēia he ala lapaʻau ikaika, ʻoi aku ka ikaika ma mua o nā lāʻau lapaʻau kuʻuna akā hiki ke hāʻawi i nā pane paʻa no ka poʻe i pane ʻole i nā maʻi maʻi i nā lāʻau lapaʻau ʻē aʻe. Aia ka ikaika i kona pololei a me ka ʻoiaʻiʻo e hana ana i kahi hoʻomanaʻo immune mau loa e kūʻē i ka maʻi maʻi.
Hāʻawi ʻia ʻo Lisocabtagene maraleucel ma ke ʻano he infusion intravenous hoʻokahi i loko o kahi hale lapaʻau maʻi maʻi kūikawā e nā poʻe loea mālama ola i hoʻomaʻamaʻa ʻia. ʻAʻole ʻoe e lawe i kēia lāʻau ma ka home, a pono ka hana holoʻokoʻa i ka hoʻonohonoho pono ʻana ma waena o ʻoe, kāu hui mālama ola, a me ka hale hana kūikawā e hoʻomākaukau ana i kāu mau keena.
Ma mua o ka loaʻa ʻana o ka infusion, e hele ʻoe i kahi regimen chemotherapy conditioning ma kahi o hoʻokahi pule ma mua e kōkua i ka hoʻomākaukau ʻana i kou kino no nā T-cells i hoʻololi ʻia. I ka lā infusion, e loaʻa iā ʻoe ka lāʻau lapaʻau ma o kahi laina IV, a ʻo ka infusion maoli e lawe ma kahi o 30 mau minuke e hoʻopau.
ʻAʻole pono ʻoe e ʻai a inu paha i kekahi mea kūikawā ma mua o ka lapaʻau, akā hiki i kāu hui mālama ola ke hāʻawi iā ʻoe i nā lāʻau lapaʻau e kōkua i ka pale ʻana i nā hopena ʻaoʻao e like me ke kuni a i ʻole nā hopena maʻi. Hāʻawi ʻia ka infusion ma kahi outpatient, akā pono ʻoe e noho kokoke i ke kikowaena lapaʻau no kekahi mau pule ma hope no ka nānā pono ʻana.
Pono ka ola hou ʻana e noho i loko o kahi mamao mai kāu kikowaena lapaʻau no ka liʻiliʻi o ʻehā pule ma hope o ka hoʻokomo ʻana, no ka mea, hiki ke ulu nā hopena ʻaoʻao i nā lā a i ʻole nā pule ma hope o ka lapaʻau ʻana. E hāʻawi kāu hui mālama ola kino i nā ʻōlelo kikoʻī e pili ana i nā palena hana, ka wā e ʻimi ai i ka lāʻau lapaʻau, a me nā papa manawa o nā manawa hālāwai.
Hāʻawi ʻia ka Lisocabtagene maraleucel ma ke ʻano he hoʻokahi, hoʻokahi manawa hoʻokomo ma mua o ka lapaʻau mau e lawe pinepine ai ʻoe. Ke loaʻa iā ʻoe ka hoʻokomo ʻana, e hoʻomau nā T-cells i hoʻololi ʻia i ka hana i loko o kou kino no ka manawa lōʻihi, e hāʻawi ana i ka mana maʻi maʻi lōʻihi me ka ʻole o ka pono i nā mea hou.
Hiki ke mau nā hopena o kēia lapaʻau no nā mahina a i ʻole nā makahiki, me kekahi poʻe e ʻike ana i nā kala lōʻihi e hoʻomau ana ma hope o ka hoʻokomo mua ʻana. E nānā kāu hui mālama ola kino i kāu pane ma o nā hoʻokolohua koko maʻamau, nā kiʻi kiʻi, a me nā hoʻokolohua kino e nānā i ka maikaʻi o ka hana ʻana o ka lapaʻau.
ʻOiai ʻaʻole ʻoe e loaʻa i nā mea hou o ka lāʻau lapaʻau ponoʻī, e loaʻa iā ʻoe ka mālama ʻana i ka wā e hiki mai ana e hiki ke hoʻomau no nā makahiki ma hope o ka lapaʻau ʻana. Kōkua kēia nānā ʻana e hōʻoia i ka hana mau ʻana o ka lapaʻau a hiki i kāu hui mālama ola kino ke hoʻoponopono i nā hopena lōʻihi a i ʻole nā pilikia e kū mai ana.
I nā hihia kakaikahi kahi e hoʻi mai ai ka maʻi maʻi ma hope o ka pane mua, hiki i kāu kauka ke kūkākūkā inā kūpono ʻoe no ka lapaʻau CAR-T cell lua, ʻoiai e hilinaʻi ana kēia i nā mea he nui a ʻaʻole i ʻōlelo ʻia no nā mea a pau.
Hiki i ka Lisocabtagene maraleucel ke hana i nā hopena ʻaoʻao nui, ʻo ka mea koʻikoʻi loa ʻo ka maʻi hoʻokuʻu cytokine (CRS) a me nā pilikia neurological. Hiki mai ka CRS ke lilo kāu mau T cell i hoʻololi ʻia i mea hana loa a hoʻokuʻu i nā mea e hiki ai ke hana i ke kuni, ke koko haʻahaʻa, a me ka pilikia o ka hanu ʻana, e hana maʻamau ana i nā lā mua ma hope o ka hoʻokomo ʻana.
Hiki i ka hoʻomaopopo ʻana i ka mea e manaʻo ai ke kōkua iā ʻoe a me kou ʻohana e hoʻomākaukau no ka huakaʻi lapaʻau i mua. Hiki ke mālama ʻia ka hapa nui o nā hopena ʻaoʻao me ka mālama olakino kūpono, a e nānā pono kāu hui mālama ola iā ʻoe a loaʻa nā lāʻau lapaʻau e mākaukau e hoʻoponopono i nā pilikia i ka wā e kū mai ai.
ʻO nā hopena ʻaoʻao maʻamau e ʻike ai ka poʻe he nui:
He manawa pōkole kēia mau hopena maʻamau a hoʻomaikaʻi i ka wā e hoʻoponopono ai kou kino i ka lāʻau lapaʻau, ʻoiai ʻokoʻa ka manawa no kēlā me kēia kanaka.
Pono nā hopena ʻaoʻao koʻikoʻi i ka lāʻau lapaʻau koke a komo pū:
E nānā pono kāu hui mālama ola iā ʻoe no kēia mau pilikia koʻikoʻi a loaʻa nā lāʻau lapaʻau kūikawā e mālama pono iā lākou i ka wā e hana ai.
ʻO kekahi mau hopena lōʻihi lōʻihi akā he mea nui e komo pū:
ʻOiai he mea hopohopo kēia mau hopena kakaʻikahi, nui ka poʻe i ʻike i ka pono o ka loaʻa ʻana o ke kala ʻana i ka maʻi 'aʻai ma mua o kēia mau pilikia, ʻoiai inā ʻaʻole i holomua nā lāʻau lapaʻau ʻē aʻe.
ʻAʻole kūpono ʻo Lisocabtagene maraleucel no nā mea a pau, a e loiloi pono kāu hui mālama ola inā he moho maikaʻi ʻoe no kēia lapaʻau. Pono ka poʻe me nā maʻi ikaika a ʻaʻole i mālama ʻia e kali a hiki i ka mālama ʻia ʻana o ka maʻi ma mua o ka hoʻomau ʻana me ka lāʻau lapaʻau CAR-T cell.
E loiloi kāu kauka i kekahi mau mea e hoʻoholo ai inā kūpono kēia lapaʻau iā ʻoe. Hiki i kekahi mau maʻi olakino a me nā kūlana ke hana i kēia lāʻau lapaʻau i mea pilikia loa a i ʻole ka liʻiliʻi o ka hopena no kou kūlana.
ʻO nā kūlana e pale ai iā ʻoe mai ka loaʻa ʻana o kēia lapaʻau, penei:
ʻAʻole kēia mau mea e hoʻokaʻawale iā ʻoe, akā pono lākou e noʻonoʻo pono a i kekahi manawa i nā hoʻokolohua a i ʻole ka lapaʻau hou ma mua o ka hoʻomau ʻana.
E noʻonoʻo nō hoʻi kāu hui mālama ola i kou pae olakino holoʻokoʻa, ka ʻōnaehana kākoʻo ma ka home, a me ka hiki ke noho kokoke i ke kikowaena lapaʻau no ka nānā ʻana. He mea nui ka loaʻa ʻana o kahi pūnaewele kākoʻo ikaika no ka mea e pono ai ʻoe i ke kōkua me nā hana o kēlā me kēia lā i ka wā e ola ana a me kekahi e nānā i nā hōʻailona e pili ana.
ʻAʻole hoʻokaʻawale wale ka makahiki iā ʻoe mai ka lapaʻau ʻana, akā hiki i nā mākua kahiko ke kū i nā pilikia hou aʻe e pono e kaupaona ʻia e kūʻē i nā pōmaikaʻi. E kūkākūkā kāu kauka i kēia mau mea pilikia pilikino me ʻoe e kōkua i ka hana ʻana i ka hoʻoholo maikaʻi loa no kāu kūlana kikoʻī.
Hoʻolaha ʻia ʻo Lisocabtagene maraleucel ma lalo o ka inoa brand Breyanzi ma ʻAmelika Hui Pū ʻIa a me nā ʻāina ʻē aʻe. ʻO kēia inoa brand ka mea āu e ʻike ai ma kāu pepa lapaʻau, nā kamaʻilio ʻinikua, a me nā pepa ʻike lāʻau.
Hana ʻia ka lāʻau lapaʻau e Bristol Myers Squibb, a hiki iā ʻoe ke ʻike i ka inoa generic (lisocabtagene maraleucel) a me ka inoa brand (Breyanzi) i hoʻohana ʻia ma nā moʻolelo olakino. E pili ana nā inoa ʻelua i ka lapaʻau like, no laila mai huikau inā ʻoe e ʻike i nā ʻōlelo like ʻole i nā palapala like ʻole.
No ka mea he lāʻau lapaʻau kūikawā kēia e koi ai i ka hana maʻamau no kēlā me kēia mea maʻi, ʻaʻole i loaʻa ma o nā hale kūʻai lāʻau lapaʻau maʻamau e like me nā lāʻau lapaʻau maʻamau. Akā, ua hāʻawi ʻia ma o kahi pūnaewele o nā kikowaena lapaʻau i hōʻoia ʻia i loaʻa nā hale kūikawā a me ka loea e pono ai e mālama pono i ka lāʻau lapaʻau CAR-T cell.
Nui nā lāʻau lapaʻau ʻē aʻe no ka poʻe me ka lymphoma cell B nui i hoʻi hou a i ʻole refractory, ʻoiai ʻo ke koho maikaʻi loa e pili ana i kāu kūlana olakino kikoʻī a me nā lāʻau lapaʻau mua. ʻO nā lāʻau lapaʻau CAR-T cell ʻē aʻe e like me axicabtagene ciloleucel (Yescarta) a me tisagenlecleucel (Kymriah) e hana like me lisocabtagene maraleucel akā he ʻokoʻa iki nā hopena ʻaoʻao.
ʻO nā koho lapaʻau kuʻuna e komo pū ana me ka chemotherapy kiʻekiʻe i ukali ʻia e ka transplant cell stem, hiki ke maikaʻi no kekahi poʻe i lawa ke olakino e ʻae i kēia ala ikaika. Ke hoʻomohala ʻia nei nā lāʻau lapaʻau i manaʻo ʻia a me nā immunotherapies hou aʻe a hiki ke loaʻa ma o nā hoʻokolohua lapaʻau.
Hiki i kekahi poʻe ke noʻonoʻo i ka chimeric antigen receptor natural killer (CAR-NK) cell therapy, he ala lapaʻau e puka mai ana e hoʻohana ana i nā cell killer maoli ma kahi o nā cell T. Eia naʻe, he mea hoʻokolohua nui kēia lapaʻau a loaʻa nui ma o nā haʻawina noiʻi.
E kūkākūkā kāu hui mālama ola i kēia mau koho ʻē aʻe e pili ana i kāu ʻano lymphoma, ke olakino holoʻokoʻa, nā lapaʻau mua, a me nā makemake pilikino. ʻO ka hoʻoholo pinepine e pili ana i ka loiloi ʻana i nā pōmaikaʻi kūpono e kūʻē i nā pilikia a me nā hopena ʻaoʻao o kēlā me kēia ala.
He maikaʻi nā lāʻau lapaʻau cell CAR-T ʻo Lisocabtagene maraleucel a me axicabtagene ciloleucel no nā ʻano lymphoma like, akā he mau ʻokoʻa ko lākou i ke ʻano o ka hana ʻana a me kā lākou mau ʻaoʻao hopena. Hiki iā Lisocabtagene maraleucel ke kumu i ka maʻi hoʻokuʻu cytokine a me nā hopena neurological ma kahi liʻiliʻi ma mua o axicabtagene ciloleucel, ʻoiai hiki i nā lāʻau lapaʻau ʻelua ke kumu i kēia mau pilikia.
ʻO ke koho ma waena o kēia mau lāʻau lapaʻau e pili pinepine ana i nā mea e like me nā manawa hana, ka ʻike o kāu kikowaena lapaʻau me kēlā me kēia lāʻau lapaʻau, a me kāu mau mea pilikia pilikino. Loaʻa paha i kekahi mau kikowaena lapaʻau ka ʻike hou aku me kekahi lāʻau lapaʻau ma mua o kekahi, hiki ke hoʻopili i nā ʻōlelo aʻoaʻo lapaʻau.
Hōʻike ka ʻikepili hoʻokolohua lapaʻau i ka like o ka maikaʻi o nā lapaʻau ʻelua no ka loaʻa ʻana o ke kala ʻana, me nā helu pane maʻamau mai 60-80% i ka poʻe me ka lymphoma nui B-cell i hoʻihoʻi ʻia a i ʻole refractory. Me he mea lā ua like ka lōʻihi o nā pane ma waena o nā lāʻau lapaʻau ʻelua, me ka nui o nā kānaka e mālama ana i ke kala ʻana no nā manawa lōʻihi.
E noʻonoʻo kāu hui mālama ola i kāu mōʻaukala olakino kikoʻī, nā ʻano o kāu lymphoma, a me nā mea hana e like me ka uhi ʻinikua a me nā hiki o ke kikowaena lapaʻau i ka wā e ʻōlelo ai i ka lāʻau lapaʻau CAR-T cell e kūpono iā ʻoe. ʻAʻole ʻoi aku ka maikaʻi o kekahi lāʻau lapaʻau ma mua o kekahi, a ua pilikino loa ka hoʻoholo.
Hiki ke hoʻohana ʻia ʻo Lisocabtagene maraleucel i ka poʻe me ka maʻi puʻuwai, akā pono ia i ka loiloi a me ka nānā pono ʻana ma muli o ka hiki ʻana o ka maʻi hoʻokuʻu cytokine e pili i ka hana o ka puʻuwai. E hana pū kāu cardiologist a me ka oncologist e loiloi inā ua paʻa kou maʻi puʻuwai e ʻae i ka lāʻau lapaʻau a me kāna mau hopena ʻaoʻao.
Ma mua o ka lapaʻau ʻana, e hana paha ʻoe i nā hoʻokolohua hana puʻuwai e like me ka echocardiogram a i ʻole MUGA scan e hoʻokumu i nā ana kumu. I ka wā a ma hope o ka lapaʻau ʻana, e nānā pono kāu hui mālama ola i kou puʻuwai, ʻoiai inā e hoʻomohala ʻoe i ka maʻi hoʻokuʻu cytokine, hiki ke hoʻohaʻahaʻa i ke koko a pili i ka puʻuwai.
Hiki i ka poʻe me nā maʻi puʻuwai i mālama maikaʻi ʻia ke loaʻa i kēia lāʻau lapaʻau me ka kūleʻa, akā pono paha ka poʻe me ka maʻi puʻuwai koʻikoʻi a paʻa ʻole e hoʻopaʻa mua i ko lākou kūlana a i ʻole e noʻonoʻo i nā lāʻau lapaʻau ʻē aʻe. E kōkua kāu hui mālama ola e hoʻoholo i ke ala maikaʻi loa no kāu kūlana.
ʻAʻole hiki ke loaʻa ka overdose me ka lisocabtagene maraleucel no ka mea ua hana kūikawā ʻia kēlā me kēia mahele no nā maʻi pākahi a hāʻawi ʻia e nā limahana mālama ola i aʻo ʻia ma nā kikowaena lapaʻau kūikawā. Hāʻawi ʻia ka lāʻau lapaʻau ma ke ʻano he mahele hoʻokahi, i hoʻoholo mua ʻia e pili ana i kou kaumaha kino a me nā koi olakino.
Inā he mau hopohopo kāu e pili ana i kāu mahele a i ʻole ka lapaʻau, e kūkākūkā koke me kāu hui mālama ola. Hiki iā lākou ke loiloi i kāu hoʻolālā lapaʻau, wehewehe i ke kaʻina hana helu ʻana i ka mahele, a pane i nā nīnau āu e loaʻa ai e pili ana i ka palekana a me ke kūpono o kāu mahele kikoʻī.
Aia i loko o ke kaʻina hana hana nā loiloi mana maikaʻi he nui e hōʻoia i ka hoʻomākaukau ʻia ʻana o ka mahele kūpono no kēlā me kēia maʻi, a me nā protocols hoʻokele e pili ana i nā ʻanuʻu hōʻoia e pale ai i nā hewa dosing. E hahai ana kāu hui mālama ola i nā kaʻina hana koʻikoʻi e hōʻoia e loaʻa iā ʻoe ka nui kūpono o ka lāʻau lapaʻau.
ʻAʻole he mea e hopohopo ai ka hala ʻana i kahi mahele o lisocabtagene maraleucel no ka mea ua hāʻawi ʻia ma ke ʻano he infusion hoʻokahi i kahi hoʻonohonoho olakino i mālama ʻia ma mua o ka lāʻau lapaʻau āu e lawe ai ma ka home. Ua hoʻonohonoho kūikawā ʻia ka lapaʻau no ʻoe, a e hōʻoia kāu hui mālama ola e loaʻa iā ʻoe ka infusion i ka manawa kūpono.
Inā pale nā kūlana i manaʻo ʻole ʻia iā ʻoe mai ka loaʻa ʻana o kāu infusion i hoʻonohonoho ʻia, e like me ka maʻi a i ʻole ka pilikia, e hana pū kāu hui mālama ola me ʻoe e hoʻonohonoho hou i ka lapaʻau i ka wā e palekana ai ke hoʻomau. Pono paha lākou e hana hou i kekahi mau hoʻokolohua ma mua o ka lapaʻau a i ʻole e hoʻoponopono i kāu papa hana chemotherapy.
I nā hihia kakaʻikahi kahi e pau ai nā cell i hana ʻia ma mua o kou hiki ke loaʻa iā lākou, pono paha e hana hou ke kaʻina hana, e hoʻomaka ana me ka hōʻiliʻili ʻana i nā cell hou. E alakaʻi kāu hui mālama ola iā ʻoe ma nā hoʻoponopono e pono ai i kāu manawa lapaʻau a e hōʻoia e loaʻa iā ʻoe ka lāʻau lapaʻau ke mākaukau ʻoe.
ʻAʻole ʻoe e "hōʻoki i ka lawe ʻana" iā lisocabtagene maraleucel ma ke ʻano kuʻuna no ka mea, hāʻawi ʻia ia ma ke ʻano he hoʻokahi infusion ma mua o ka lāʻau lapaʻau e hoʻomau nei. Ke loaʻa iā ʻoe ka lapaʻau, e hoʻomau nā T-cells i hoʻololi ʻia i loko o kou kino no ka manawa lōʻihi, e hāʻawi ana i ka mana maʻi maʻi lōʻihi.
Hiki i nā hopena o ka lapaʻau ke mau no nā mahina a i ʻole nā makahiki, a ʻaʻohe ala e "hoʻopau" i nā cell i hoʻololi ʻia i loko o kāu ʻōnaehana. ʻO kēia kekahi o nā mea maikaʻi o ka CAR-T cell therapy, no ka mea, hiki iā ia ke hāʻawi i nā remissions paʻa me ka ʻole o ka pono e hana hou i nā lapaʻau.
E hoʻomau ka mālama ʻana i kāu hahai ʻana ma hope o ka lapaʻau mua, me ka nānā mau ʻana e loiloi i ka maikaʻi o ka hana ʻana o ka therapy a e nānā i nā hopena lōʻihi. He mea nui kēia mālama mau no ka mālama ʻana i kou olakino a me ka hopu ʻana i nā pilikia hiki ke hiki i ka wā mua.
Ua kaupalena ʻia ka huakaʻi no ka liʻiliʻi o ʻehā pule ma hope o ka loaʻa ʻana iā lisocabtagene maraleucel no ka mea hiki ke hoʻomohala ʻia nā hopena ʻaoʻao koʻikoʻi i kēia manawa a pono e mālama koke ʻia e kāu hui lapaʻau. Pono ʻoe e noho i loko o kahi mamao mai kāu kikowaena lapaʻau, maʻamau i loko o ʻelua hola o ka manawa huakaʻi.
Ma hope o ka manawa nānā mua, ua hoʻokuʻu ʻia nā palena huakaʻi, akā pono ʻoe e hoʻomaopopo mau i kāu hui mālama ola i kāu mau hoʻolālā huakaʻi. Hiki iā lākou ke hāʻawi iā ʻoe i ka ʻike lapaʻau e kaʻana like me nā mea mālama ola inā pono ʻoe i ka mālama olakino i ka wā e haʻalele ai i kāu kikowaena lapaʻau.
Hiki i ka huakaʻi lōʻihi a i ʻole ka huakaʻi honua ke koi i ka hoʻolālā hou ʻana, me ka hōʻoia ʻana iā ʻoe i ke komo ʻana i ka mālama olakino kūpono a me ka lawe ʻana i nā palapala e pili ana i kāu lapaʻau. Hiki i kāu hui mālama ola ke kōkua iā ʻoe e hoʻolālā i ka huakaʻi palekana a hāʻawi i ke alakaʻi ʻana i nā hana e hana ai i ka wā e haʻalele ai i ka home.
6Mpeople
Get clear medical guidance
on symptoms, medications, and lab reports.